| Product Code: ETC6271293 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Imaging agents are critical for enhancing the visibility of organs, tissues, and blood vessels during diagnostic imaging procedures. In Bahrain, the market includes contrast agents used in MRI, CT, and ultrasound scans. Growing diagnostic imaging volumes and increasing chronic disease cases are key drivers. Regulatory oversight ensures safety and efficacy of agents, especially those involving iodine or gadolinium. Hospitals often source these from multinational pharmaceutical companies. The market is expected to expand as diagnostic accuracy becomes a higher priority in patient care.
The medical imaging agents market in Bahrain is growing steadily with increasing use of contrast agents to improve image clarity and diagnostic accuracy across MRI, CT, ultrasound, and nuclear medicine. Demand is driven by rising prevalence of chronic diseases requiring imaging for diagnosis and treatment monitoring. The market is shaped by stringent regulatory standards governing safety and efficacy. Innovations focus on developing agents with enhanced specificity, reduced toxicity, and longer circulation times. Import dependence is high due to specialized manufacturing requirements. Collaboration between pharmaceutical companies and healthcare providers facilitates product availability. The market outlook remains positive as imaging utilization continues to rise.
The supply of medical imaging agents such as contrast media is challenged by import dependency and stringent regulatory approval processes. Storage and transportation require strict temperature control, complicating logistics. The market is sensitive to pricing, as healthcare providers seek cost-effective options without compromising quality. Adverse reactions to contrast agents necessitate careful patient screening and staff training, which is inconsistent across facilities. Limited local availability of a broad range of agents restricts diagnostic flexibility. Procurement delays impact timely imaging services. Additionally, there are environmental concerns about the disposal of imaging agent waste that require attention.
Bahrains growing number of imaging procedures has boosted demand for contrast agents and radiopharmaceuticals. Investment potential lies in importing or manufacturing high-quality imaging agents used in MRI, CT, and PET scans. Companies with regulatory-compliant formulations and partnerships with diagnostic centers can secure steady demand. Theres also room to invest in specialized agents for oncology and neurological imaging. As Bahrain strengthens its diagnostic capabilities, theres likely to be growing emphasis on safety, efficacy, and innovation in contrast media. Establishing localized production or regional distribution hubs can also reduce dependency on imports.
Medical imaging phantoms, used for calibration and testing of imaging devices, are subject to regulatory oversight in Bahrain. The NHRA mandates that all phantoms used in healthcare facilities meet international quality standards. Regular testing and maintenance of imaging equipment using phantoms are required to ensure accurate diagnostics. The Ministry of Health provides guidelines on the proper use and storage of these devices. Training programs are available for technicians on the utilization of phantoms in quality assurance procedures. Suppliers must obtain NHRA approval before distributing phantoms to healthcare providers. The government encourages research into the development of advanced phantoms for emerging imaging technologies. These measures aim to maintain high standards in medical imaging across Bahrain.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bahrain Medical Imaging Agents Market Overview |
3.1 Bahrain Country Macro Economic Indicators |
3.2 Bahrain Medical Imaging Agents Market Revenues & Volume, 2021 & 2031F |
3.3 Bahrain Medical Imaging Agents Market - Industry Life Cycle |
3.4 Bahrain Medical Imaging Agents Market - Porter's Five Forces |
3.5 Bahrain Medical Imaging Agents Market Revenues & Volume Share, By Isotope, 2021 & 2031F |
3.6 Bahrain Medical Imaging Agents Market Revenues & Volume Share, By Modality, 2021 & 2031F |
3.7 Bahrain Medical Imaging Agents Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Bahrain Medical Imaging Agents Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Bahrain Medical Imaging Agents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increase in chronic diseases and demand for early diagnosis |
4.2.2 Technological advancements in medical imaging agents |
4.2.3 Growing investments in healthcare infrastructure in Bahrain |
4.3 Market Restraints |
4.3.1 High cost associated with medical imaging agents |
4.3.2 Stringent regulatory requirements for approval of imaging agents |
5 Bahrain Medical Imaging Agents Market Trends |
6 Bahrain Medical Imaging Agents Market, By Types |
6.1 Bahrain Medical Imaging Agents Market, By Isotope |
6.1.1 Overview and Analysis |
6.1.2 Bahrain Medical Imaging Agents Market Revenues & Volume, By Isotope, 2021- 2031F |
6.1.3 Bahrain Medical Imaging Agents Market Revenues & Volume, By Technetium, 2021- 2031F |
6.1.4 Bahrain Medical Imaging Agents Market Revenues & Volume, By Thallium, 2021- 2031F |
6.1.5 Bahrain Medical Imaging Agents Market Revenues & Volume, By Gallium, 2021- 2031F |
6.1.6 Bahrain Medical Imaging Agents Market Revenues & Volume, By Iodine, 2021- 2031F |
6.1.7 Bahrain Medical Imaging Agents Market Revenues & Volume, By Samarium, 2021- 2031F |
6.1.8 Bahrain Medical Imaging Agents Market Revenues & Volume, By Rhenium, 2021- 2031F |
6.1.9 Bahrain Medical Imaging Agents Market Revenues & Volume, By Gallium, 2021- 2031F |
6.1.10 Bahrain Medical Imaging Agents Market Revenues & Volume, By Gallium, 2021- 2031F |
6.2 Bahrain Medical Imaging Agents Market, By Modality |
6.2.1 Overview and Analysis |
6.2.2 Bahrain Medical Imaging Agents Market Revenues & Volume, By X-Ray/CT, 2021- 2031F |
6.2.3 Bahrain Medical Imaging Agents Market Revenues & Volume, By MRI, 2021- 2031F |
6.2.4 Bahrain Medical Imaging Agents Market Revenues & Volume, By Ultrasound, 2021- 2031F |
6.2.5 Bahrain Medical Imaging Agents Market Revenues & Volume, By SPECT, 2021- 2031F |
6.2.6 Bahrain Medical Imaging Agents Market Revenues & Volume, By PET, 2021- 2031F |
6.3 Bahrain Medical Imaging Agents Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Bahrain Medical Imaging Agents Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.3.3 Bahrain Medical Imaging Agents Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3.4 Bahrain Medical Imaging Agents Market Revenues & Volume, By Gastrointestinal, 2021- 2031F |
6.3.5 Bahrain Medical Imaging Agents Market Revenues & Volume, By Musculoskeletal, 2021- 2031F |
6.3.6 Bahrain Medical Imaging Agents Market Revenues & Volume, By Neurology, 2021- 2031F |
6.3.7 Bahrain Medical Imaging Agents Market Revenues & Volume, By Nephrology, 2021- 2031F |
6.3.8 Bahrain Medical Imaging Agents Market Revenues & Volume, By Pulmonary, 2021- 2031F |
6.3.9 Bahrain Medical Imaging Agents Market Revenues & Volume, By Pulmonary, 2021- 2031F |
6.4 Bahrain Medical Imaging Agents Market, By End Users |
6.4.1 Overview and Analysis |
6.4.2 Bahrain Medical Imaging Agents Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.4.3 Bahrain Medical Imaging Agents Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.4.4 Bahrain Medical Imaging Agents Market Revenues & Volume, By Academic Institutes and Research Organizations, 2021- 2031F |
7 Bahrain Medical Imaging Agents Market Import-Export Trade Statistics |
7.1 Bahrain Medical Imaging Agents Market Export to Major Countries |
7.2 Bahrain Medical Imaging Agents Market Imports from Major Countries |
8 Bahrain Medical Imaging Agents Market Key Performance Indicators |
8.1 Adoption rate of new medical imaging technologies in Bahrain |
8.2 Number of partnerships and collaborations between healthcare providers and imaging agents manufacturers |
8.3 Rate of utilization of medical imaging agents in different medical facilities. |
9 Bahrain Medical Imaging Agents Market - Opportunity Assessment |
9.1 Bahrain Medical Imaging Agents Market Opportunity Assessment, By Isotope, 2021 & 2031F |
9.2 Bahrain Medical Imaging Agents Market Opportunity Assessment, By Modality, 2021 & 2031F |
9.3 Bahrain Medical Imaging Agents Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Bahrain Medical Imaging Agents Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Bahrain Medical Imaging Agents Market - Competitive Landscape |
10.1 Bahrain Medical Imaging Agents Market Revenue Share, By Companies, 2024 |
10.2 Bahrain Medical Imaging Agents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |